Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Metformin regulates breast cancer stem cell ontogeny by transcriptional regulation of the epithelial-mesenchymal transition (EMT) status.

Cell cycle (Georgetown, Tex.) - 15 Sept 2010

Vazquez-Martin Alejandro, Oliveras-Ferraros Cristina, Cufí Silvia, Del Barco Sonia, Martin-Castillo Begoña, Menendez Javier A

Abstract excerpt

The sole overexpression of pivotal regulators of the embryonic Epithelial-Mesenchymal Transition (EMT) genetic program ("EMT status") may be sufficient to efficiently drive the ontogeny of the breast cancer stem cell molecular signature independently of changes in EMT functioning ("EMT phenotype"...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to CD24 Antigen
Share to Epithelial-Mesenchymal Transition

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hyaluronan Receptors

Share to Hypoglycemic Agents

Share to Metformin

Share to Neoplastic Stem Cells

Share to Transcription, Genetic

Source

Identifiers

PMID: 20890129

Genes

SNAI2
TWIST1
ZEB1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20890129-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Metformin regulates breast cancer stem cell ontogeny by transcriptional regulation of the epithelial-mesenchymal transition (EMT) status.PMID 20890129Read ↗

Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progressionSemantic proximity Read ↗

SLUG/SNAI2 and tumor necrosis factor generate breast cells with CD44+/CD24- phenotype.Semantic proximity Read ↗

Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/)CD24 (lo/-) stem cell phenotype in human breast cancer.Semantic proximity Read ↗

Epithelial-Mesenchymal Transition Programs and Cancer Stem Cell Phenotypes: Mediators of Breast Cancer Therapy Resistance.Semantic proximity Read ↗

A mechanism-based computational model to capture the interconnections among epithelial-mesenchymal transition, cancer stem cells and Notch-Jagged signalingSemantic proximity Read ↗

The anti-diabetic drug metformin suppresses self-renewal and proliferation of trastuzumab-resistant tumor-initiating breast cancer stem cells.Semantic proximity Read ↗

Epithelial and mesenchymal subpopulations within normal basal breast cell lines exhibit distinct stem cell/progenitor properties.Semantic proximity Read ↗

Counteracting Chemoresistance with Metformin in Breast Cancers: Targeting Cancer Stem CellsSemantic proximity Read ↗

Cell State Transitions and Phenotypic Heterogeneity in Luminal Breast Cancer Implicating MicroRNAs as Potential Regulators.Semantic proximity Read ↗

PD‐L1 promotes OCT4 and Nanog expression in breast cancer stem cells by sustaining PI3K/AKT pathway activationSemantic proximity Read ↗

Breast cancer stem cell markers – the rocky road to clinical applicationsSemantic proximity Read ↗

Oncostatin-M promotes phenotypic changes associated with mesenchymal and stem cell-like differentiation in breast cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.